UK markets closed

Kiromic BioPharma, Inc. (KRBP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2701-0.0049 (-1.78%)
At close: 12:59PM EST
0.2750 +0.00 (+1.81%)
After hours: 02:07PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
13,928
11,368
5,053
1,202
1,425
Selling general and administrative
20,500
13,938
14,144
2,504
1,758
Total operating expenses
34,428
25,306
19,197
3,705
3,183
Operating income or loss
-34,428
-25,306
-19,197
-3,705
-3,183
Interest expense
12.8
12.2
3.3
22.5
633.1
Total other income/expenses net
-3,858
-270.8
-
-
-
Income before tax
-38,298
-25,589
-19,200
-3,728
-3,816
Income tax expense
-
-
-
0
0
Income from continuing operations
-38,298
-25,589
-19,200
-3,728
-3,816
Net income
-38,298
-25,589
-19,200
-3,728
-3,816
Net income available to common shareholders
-38,643
-25,811
-19,913
-3,728
-3,816
Basic EPS
-
-2.26
-4.42
-1.06
-1.08
Diluted EPS
-
-2.26
-4.42
-1.06
-1.08
Basic average shares
-
11,417
4,506
3,533
3,533
Diluted average shares
-
11,417
4,506
3,533
3,533
EBITDA
-
-25,107
-18,997
-3,618
-3,102